Morrison Brent 4

What Happened Brent Morrison, CEO, President and Director of Regional Health Properties, Inc. (RHEP), received two grants on January 16, 2026: 100,000 restricted shares (reported acquisition at $0.00) and 100,000 derivative awards (stock options, reported acquisition at $0.00). Both awards were granted under RHEP’s Amended and Restated 2023 Omnibus Incentive Compensation Plan and were reported with a $0 acquisition price (no cash paid).

Key Details

• Transaction date: January 16, 2026; Form 4 filed February 4, 2026 (appears late vs. the usual 2-business-day Form 4 deadline).
• Grants:
  • 100,000 restricted shares (footnote F1) — vest 50,000 on Jan 16, 2027 and 50,000 on Jan 16, 2028 (F2).
  • 100,000 derivative awards/stock options — vest 50,000 on Jan 16, 2027 and 50,000 on Jan 16, 2028 (F4).
• Reported acquisition price: $0.00 for both grants; footnote F3 references the OTC average price on Jan 16, 2026 used for reporting context.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Filing timeliness: Form filed Feb 4, 2026 for a Jan 16 transaction — this is later than the typical 2-business-day requirement and may be noted as delinquent.

Context

• These are long-term incentive grants, not open-market purchases or sales; vesting over two years means the awards are contingent on continued service (and possibly other plan conditions).
• The derivative entry reflects option-like awards (not an immediate exercise or sale); if and when options vest and are exercised, further Form 4 filings would disclose any sale or purchase details.
• For retail investors: grants are common for executives as compensation/retention and do not by themselves indicate immediate buying or selling of stock. Late filing can delay market transparency until disclosure.